Share BuybackAlways a sign that the company feels that their stock is undervalued. GLTA
09:03 AM EST, 12/11/2020 (MT Newswires) -- The TSXV has accepted BioSyent's Notice of Intention to Make a Normal Course Issuer Bid, allowing the company to buy back up to 950,000 of its common shares over a 12-month period, approximately 7.42% of the shares outstanding.
The NCIB will commence on Dec 17 and terminate on Dec 16, 2021.
BioSyent has entered into an automatic share purchase plan with a broker, Raymond James, to allow for share purchases during certain pre-determined blackout periods.
Price: 6.92, Change: -0.08, Percent Change: -1.14